The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatologists Respond to Prescription Opioid Analgesic Crisis

Rheumatologists Respond to Prescription Opioid Analgesic Crisis

May 16, 2017 • By Larry Beresford

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Prokopenko Oleg/shutterstock.com

Prokopenko Oleg/shutterstock.com

The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor.

You Might Also Like
  • Neurontin Prescriptions Surge Amid Opioid Crisis
  • FDA Says It Requires Boxed Warning on Some Opioid-Based Painkillers
  • New Jersey Sues OxyContin Maker, Links Marketing to Opioid Crisis
Explore This Issue
May 2017
Also By This Author
  • Doctors & Political Advocacy: Tips to Get You Started

Meanwhile, a lack of rigorous research demonstrating long-term effectiveness of opioids in relieving chronic, non-cancer pain contrasts with well-documented adverse events from these prescriptions, including opioid use disorder and resulting social problems, high rates of emergency room visits and hyperalgesia—even increased risk of nonvertebral fracture for rheumatoid arthritis (RA) patients on opioid analgesics.2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Many stakeholders in the opioid overdose epidemic, including the Drug Enforcement Administration, Surgeon General, Food and Drug Administration, law enforcement, legislators, hospitals and medical associations, are all saying the same thing: Doctors are writing too many opioid prescriptions.

So how are frontline providers responding? Opioids are still part of the analgesic armamentarium used by rheumatologists, and an individualized, evidence-based approach tailored to each patient is the recommended strategy. “But studies don’t have that much data to show that opioids help my patients,” says Philip J. Molloy, MD, FACP, a rheumatologist at Beth Israel Deaconess Hospital in Plymouth, Mass.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In 2015, more than 33,000 Americans died from overdoses of legal and illegal opioids. One-fifth of patients with non-cancer pain will receive an opioid prescription and one out of four who receives long-term opioid therapy in a primary care setting will struggle with addiction, according to the CDC. Problems from prescription drugs include patients taking drugs as prescribed but having adverse reactions, as well as using prescriptions for nonmedical reasons and diversion of prescribed drugs.

However, unaddressed chronic pain was described by the Institute of Medicine (IOM) in 2011 as another major public health concern—one costing between $560 billion and $635 billion per year in medical care, missed work and lost productivity.3 The IOM concluded that more than 100 million Americans suffer each year from chronic pain lasting 30 to 60 days or more. Musculoskeletal sources of pain are common, and many of those with chronic pain are patients with rheumatologic conditions who visit rheumatologists.

Concerns about untreated pain and the vast suffering it represents were behind a pendulum swing toward more aggressive treatment of pain over the past two decades. And now the pendulum has swung back to where the Centers for Medicare and Medicaid Services plans to drop some pain-related questions from its hospital patient satisfaction surveys out of concern that such questions have encouraged hospitals to overprescribe opioids. Others have sought to end Pain as a Fifth Vital Sign programs that routinely ask patients to rate their subjective experience of pain on a 0 to 10 scale. A California legislator in March proposed imposing a tax on opioid wholesalers for OxyContin and other opioids, with proceeds going to fund drug rehabilitation services.4

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

‘We understand the challenge of the difficult patient, & chronic, untreated pain is very real for some of our patients.’ —Ronald Rapoport, MD

What Is the Rheumatologist’s Role?

Rheumatologists confront these issues every day, says Ronald Rapoport, MD, chief of the Division of Rheumatology for Southcoast Health in Fall River, Mass. They try to resolve their patients’ pain by reducing the underlying disease with disease-modifying anti-rheumatic drugs and other treatments, he says. “We understand the challenge of the difficult patient, and chronic, untreated pain is very real for some of our patients.”

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Analgesics, Drug Updates, Practice Management, Safety Tagged With: Addiction, analgesic, Chronic pain, crisis, epidemic, Management, opioid, Overdose, patient care, prescription, Rheumatic Disease, rheumatologist, rheumatology, risk, Safety, TreatmentIssue: May 2017

You Might Also Like:
  • Neurontin Prescriptions Surge Amid Opioid Crisis
  • FDA Says It Requires Boxed Warning on Some Opioid-Based Painkillers
  • New Jersey Sues OxyContin Maker, Links Marketing to Opioid Crisis
  • Monitoring Doctors Cuts Opioid Prescriptions

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.